Parkinson's disease

Journal of the American Geriatrics Society

Volumn 45, Issue 2, 1997, Pages 233-240

  Nadeau, Stephen E ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; PERGOLIDE; SELEGILINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; NEUROTOXICITY; PARKINSON DISEASE; TREATMENT PLANNING; VERTIGO; XEROSTOMIA;

EID: 0031013267     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb04514.x     Document Type: Article

References (27)

1. The Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989;321:1364-1371.
2. Schulzer M, Mak E, Calne DB. The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic. Ann Neurol 1992;32:795-798.
3. Lees AJ. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Br Med J 1995;311:1602-1607.
4. Fahn S, Bressman SB. Should levodopa for Parkinsonism be started early or late? Evidence against early treatment. Can J Neurol Sci 1984;11:200-206.
5. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695.
6. Olanow CW. A radical hypothesis for neurodegeneration. TINS 1993;16:439-444.
7. Bowling AC, Beal MF. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 1995;56:1151-1171.
8. Jenner P, Schapira AH, Marsden CD. New insights into the cause of Parkinson's disease. Neurology 1992;42:2241-2250.
9. Markham CH, Diamond SG. Evidence to support early levodopa therapy in Parkinson's disease. Neurology 1981;31:125-131.
10. Cedarbaum JM, Gandy SE, McDowell FH. "Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease. Neurology 1991;41:622-629.
11. de la Monte SM, Wells SE, Hedley-Whyte ET, Growdon JH. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann Neurol 1989;26:309-320.
12. Bergman H, Wichmann T, DeLong MR. Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438.
13. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994;117:877-897.
14. Svennilson E, Torvik A, Lowe R et al. Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatr Neurol Scand 1960;35:358-377.
15. Laitinen LV. Pallidotomy for Parkinson's disease. Neurosurg Clin North Am 1995;6:105-112.
16. Dogali M, Fazzini E, Kolodny E et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-761.
17. Lozano AM, Lang AE, Galvez-Jimenez N et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
18. Iacono RP, Shima F, Lonser RR et al. The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery 1995;36:1118-1125.
19. Madrazo I, Drucker-Colin R, Diaz V et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med 1987;316:831-834.
20. Golbe LI. Progressive supranuclear palsy. In: Stern MB, Koller WC, eds. Parkinsonian Syndromes. New York: Marcel Dekker, Inc., 1993, pp 227-247.
21. Daniel SE, deBruin VM, Lees AJ. The clinical and pathological sprectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): A reappraisal. Brain 1995;118:759-770.
22. Gibb WRG, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-1192.
23. Quinn N. Multiple system atrophy - The nature of the beast. J Neurol Neurosurg Psychiatry 1989;Suppl:78-89.
24. Hansen L, Solman D, Galasco D et al. The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 1990;40:1-8.
25. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990;237:197-204.
26. Crystal HA, Dickson HW, Lizardi JE et al. Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990;40:1523-1528.
27. Nadeau SE. Multi-infarct dementia, subcortical dementia, and hydrocephalus. South Med J 1991;84(Suppl 1):41-52.